These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11026033)

  • 1. [Thymidine phosphorylase as a prognostic factors of breast cancers].
    Takahashi H; Todo S
    Nihon Rinsho; 2000 Apr; 58 Suppl():454-9. PubMed ID: 11026033
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients.
    Tominaga T; Toi M; Ohashi Y; Abe O;
    Clin Breast Cancer; 2002 Apr; 3(1):55-64. PubMed ID: 12020396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between elevated intratumoral thymidine phosphorylase and prognosis of node-positive breast carcinoma undergoing adjuvant doxifluridine treatment.
    Takahashi H; Maeda Y; Watanabe K; Taguchi K; Sasaki F; Todo S
    Int J Oncol; 2000 Dec; 17(6):1205-11. PubMed ID: 11078806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
    Hata Y; Takahashi H; Sasaki F; Ogita M; Uchino J; Yoshimoto M; Akasaka Y; Nakanishi Y; Sawada Y
    Breast Cancer; 2000 Jan; 7(1):37-41. PubMed ID: 11029769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
    Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
    Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase expression and effect of doxifluridine: a phase II study.
    Sadahiro S; Otani Y; Oya K; Ike H; Shimada H; Yamaguchi S; Hiki Y; Fujita H; Mitomi T
    Oncol Rep; 2001; 8(4):753-8. PubMed ID: 11410777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase?
    Bonotto M; Bozza C; Di Loreto C; Osa EO; Poletto E; Puglisi F
    Clin Breast Cancer; 2013 Jun; 13(3):167-72. PubMed ID: 23218471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Doxifluridine for treatment of colorectal cancer].
    Nishimura G; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():345-8. PubMed ID: 14574909
    [No Abstract]   [Full Text] [Related]  

  • 9. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
    Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
    Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
    Lee SJ; Choi YL; Park YH; Kim ST; Cho EY; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):743-51. PubMed ID: 21170649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-prodrug systems: thymidine phosphorylase/5'-deoxy-5-fluorouridine.
    Evrard A; Ciccolini J; Cuq P; Cano JP
    Methods Mol Med; 2004; 90():263-78. PubMed ID: 14657568
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma.
    Chen LC; Hsueh C; Tsang NM; Liang Y; Chang KP; Hao SP; Yu JS; Chang YS
    Clin Cancer Res; 2008 Jun; 14(12):3807-13. PubMed ID: 18559600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
    Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
    Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of thymidine phosphorylase expression in breast cancer--comparison of microarray and immunohistochemical data.
    Ruckhäberle E; Karn T; Engels K; Turley H; Hanker L; Müller V; Schmidt M; Ahr A; Gaetje R; Holtrich U; Kaufmann M; Rody A
    Eur J Cancer; 2010 Feb; 46(3):549-57. PubMed ID: 20022486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
    Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.
    Sato S; Yajima A; Sasaki H; Mizutani K; Honjo H; Yamamoto K; Ozaki M; Hasegawa K; Kudo T; Yakushiji M; Hatae M; Noda K
    Oncol Rep; 2001; 8(2):239-44. PubMed ID: 11182033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study).
    Mori T; Ohue M; Takii Y; Hashizume T; Kato T; Kotake K; Sato T; Tango T
    Oncol Rep; 2013 Feb; 29(2):437-44. PubMed ID: 23232805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.